Connection

Yeming Wang to Oseltamivir

Back to Details
This is a "connection" page, showing publications Yeming Wang has written about Oseltamivir.
Yeming Wang
Connection Strength
0.669
Oseltamivir
  1. Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza. EBioMedicine. 2020 Dec; 62:103125.
    View in: PubMed
    Score: 0.635
  2. Dynamic Variation and Reversion in the Signature Amino Acids of H7N9 Virus During Human Infection. J Infect Dis. 2018 07 13; 218(4):586-594.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.